Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast |
Afimoxifene, Laboratory Biomarker Analysis, Placebo, Tamoxifen Citrate |
Recruiting |
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis |
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Placebo Administration, Questionnaire Administration, Simvastatin |
Active, not recruiting |
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma |
Aspirin, Biospecimen Collection, Placebo Administration, Questionnaire Administration, Rectal Biopsy |
Active, not recruiting |
Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts |
Contrast-enhanced Magnetic Resonance Imaging, Digital Tomosynthesis Mammography, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer |
Biospecimen Collection, Retinoid 9cUAB30, Therapeutic Conventional Surgery |
Active, not recruiting |
Use of ctDNA for Monitoring of Stage III Colorectal Cancer |
|
Active, not recruiting |
Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men |
Laboratory Biomarker Analysis, Cytology Specimen Collection Procedure |
Active, not recruiting |
Chemoprevention of Gastric Carcinogenesis |
Eflornithine, Eflornithine placebo |
Active, not recruiting |
Understanding and Predicting Breast Cancer Events After Treatment |
Cardiac MRI |
Active, not recruiting |
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia |
Curcumin, Laboratory Biomarker Analysis, Placebo Administration, Quality-of-Life Assessment |
Active, not recruiting |